Home
Publications
News
About
Contact
Investor Relations
Select Page
Home
Publications
News
About
Contact
Investor Relations
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity
Filing Type:
View All
10-K
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13G
UPLOAD
Year:
View All
2024
2023
2022
2017
Date
Form
Description
PDF
XBRL
Pages
02/14/22
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
expand_more
EX-16.1
EX-21.1
88
07/26/17
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
rss_feed
Filing RSS
arrow_back
1…
14
15
16
17
18
19
20
21
22
23
Email Alerts
Contacts
RSS News Feed
Phone
(210) 698-5334
Email
info@bioaffinitytech.com
LinkedIn
…/bioaffinitytechnologies
Twitter
@bioAffinity
Subscribe for News from bioAffinity Technologies
Subscribe